Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Genotyping industry 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Products & services trends
2.1.4 Technology trends
2.1.5 Application trends
2.1.6 End-use trends
Chapter 3 Genotyping Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1 Increasing demand for personalized medicine
3.2.2 Rising incidence of genetic disorders
3.2.3 Technological advancements in genotyping platforms
3.2.4 Growing investments and funding in genomic research
3.2.2 Industry pitfalls & challenges
3.2.1 High cost of genotyping technology
3.2.2 Stringent regulatory processes
3.3 Growth potential analysis
3.3.1 By products & services
3.3.2 By technology
3.3.3 By application
3.3.4 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Genotyping Market Estimates and Forecast, By Products & Services, 2018-2032 (USD Million)
5.1 Key trends, by products & services
5.2 Reagents & kits
5.3 Instruments
5.4 Software & services
Chapter 6 Genotyping Market Estimates and Forecast, By Technology, 2018-2032 (USD Million)
6.1 Key trends, by technology
6.2 PCR
6.2.1 Real-time PCR
6.2.2 Digital PCR
6.2.3 Other PCR technologies
6.3 Sequencing
6.3.1 Next generation sequencing
6.3.2 Sanger sequencing
6.4 Microarrays
6.4.1 DNA microarrays
6.4.2 Peptide microarrays
6.4.3 Other microarray technologies
6.5 Capillary electrophoresis
6.5.1 Amplified fragment length polymorphism
6.5.2 Restriction fragment length polymorphism
6.5.3 Single-strand conformation polymorphism
6.6 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-TOF) mass spectroscopy
6.7 Other technologies
Chapter 7 Genotyping Market Estimates and Forecast, By Application, 2018-2032 (USD Million)
7.1 Key trends, by application
7.2 Diagnostics & personalized medicine
7.3 Pharmacogenomics
7.4 Animal genetics
7.5 Other applications
Chapter 8 Genotyping Market Estimates and Forecast, By End-use, 2018-2032 (USD Million)
8.1 Key trends, by end-use
8.2 Academic & research institute
8.3 Pharmaceutical & biotechnology companies
8.4 Diagnostic centers
8.5 Other end-users
Chapter 9 Genotyping Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Illumina Inc.
10.2 Thermo Fisher Scientific Inc.
10.3 QIAGEN N.V.
10.4 F. Hoffmann-La Roche Ltd.
10.5 Standard BioTools Inc.
10.6 Danaher Corporation
10.7 Agilent Technologies, Inc.
10.8 Eurofins Scientific
10.9 GE Healthcare Technologies Inc.
10.10 Bio-Rad Laboratories Inc.
